Elite Pharmaceuticals Corrects Conference Call Date for Q2 Fiscal 2026 Results

ELITE PHARMACEUTICALS INC /NV/

2026-Q2 EPS reported $0.01 revenue$76,532,801

Q2 FY2026 financial results (ended Sept 30, 2025) to be released on Friday, November 14, 2025.
Conference call scheduled for Monday, November 17, 2025 at 11:30 AM EST to discuss results and provide update.
Form 8-K/A amends prior filing solely to correct the conference call date in Item 7.01.
Dial-in: 1-800-346-7359 (domestic) or 1-973-528-0008 (international); conference ID 98840.
Stockholder questions due by 5:00 PM EST on Nov 13 (general) and 7:00 PM EST on Nov 14 (financial).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.